Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M81,621Revenue $M16,385Net Margin (%)15.6Z-Score4.1
Enterprise Value $M85,436EPS $1.5Operating Margin %18.9F-Score5
P/E(ttm))32.1Cash Flow Per Share $2.8Pre-tax Margin (%)17.6Higher ROA y-yY
Price/Book5.310-y EBITDA Growth Rate %0.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %-13.3Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %24.1ROA % (ttm)6.6Higher Current Ratio y-yY
Dividend Yield %2.9Insider Buy (3m)0ROE % (ttm)16.9Less Shares Outstanding y-yN
Payout Ratio %91.0Shares Outstanding M1,646ROI % (ttm)5.7Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYJoel Greenblatt 2013-12-31 Buy 0.02%$46.41 - $53.84
($50.96)
$ 49.46-3%New holding, 11679 sh.11,679
BMYVanguard Health Care Fund 2013-09-30 Add0.64%$41.32 - $47.53
($43.84)
$ 49.4613%Add 20.26%24,459,861
BMYJean-Marie Eveillard 2013-09-30 Reduce-0.01%$41.32 - $47.53
($43.84)
$ 49.4613%Reduce -75.17%16,520
BMYVanguard Health Care Fund 2013-06-30 Add0.39%$39.68 - $47.68
($43.41)
$ 49.4614%Add 13.32%20,338,461
BMYGeorge Soros 2013-06-30 Buy 0.05%$39.68 - $47.68
($43.41)
$ 49.4614%New holding, 100000 sh.100,000
BMYJean-Marie Eveillard 2013-06-30 Add0.01%$39.68 - $47.68
($43.41)
$ 49.4614%Add 302.66%66,520
BMYRay Dalio 2013-06-30 Sold Out -0.07%$39.68 - $47.68
($43.41)
$ 49.4614%Sold Out0
BMYPrem Watsa 2013-06-30 Sold Out -0.01%$39.68 - $47.68
($43.41)
$ 49.4614%Sold Out0
BMYVanguard Health Care Fund 2013-03-31 Add0.96%$32.59 - $41.19
($36.62)
$ 49.4635%Add 49.53%17,948,561
BMYRay Dalio 2013-03-31 Add0.05%$32.59 - $41.19
($36.62)
$ 49.4635%Add 267.87%181,140
BMYJohn Hussman 2013-03-31 Sold Out -0.64%$32.59 - $41.19
($36.62)
$ 49.4635%Sold Out0
BMYJames Barrow 2013-03-31 Sold Out -0.05%$32.59 - $41.19
($36.62)
$ 49.4635%Sold Out0
BMYJohn Hussman 2012-12-31 Reduce-0.2%$30.81 - $34.38
($32.89)
$ 49.4650%Reduce -25%750,000
BMYJames Barrow 2012-12-31 Reduce-0.02%$30.81 - $34.38
($32.89)
$ 49.4650%Reduce -22.36%795,409
BMYRay Dalio 2012-12-31 Reduce-0.01%$30.81 - $34.38
($32.89)
$ 49.4650%Reduce -21.64%49,240
BMYRay Dalio 2012-09-30 Buy 0.03%$31.53 - $36.14
($33.81)
$ 49.4646%New holding, 62840 sh.62,840
BMYPrem Watsa 2012-06-30 Reduce$32.37 - $35.49
($33.66)
$ 49.4647%Reduce -30%7,000
BMYRichard Perry 2012-06-30 Sold Out -0.04%$32.37 - $35.49
($33.66)
$ 49.4647%Sold Out0
BMYMario Gabelli 2012-03-31 Add0.06%$31.85 - $35.01
($30.47)
$ 49.4662%Add 33.64%928,152
BMYRichard Perry 2012-03-31 Buy 0.04%$31.85 - $35.01
($30.47)
$ 49.4662%New holding, 22200 sh.22,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BMY Joel Greenblatt 2013-12-3111,67900.02New Buy
BMY Vanguard Health Care Fund 2013-12-3124,459,8611.494
BMY Jean-Marie Eveillard 2013-12-3116,52000
BMY George Soros 2013-12-31100,0000.010.05
BMY Dodge & Cox 2013-12-3179,92100-0.25%
BMY Mario Gabelli 2013-12-31730,7710.040.21-5.08%
Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Caldarella Joseph CSVP & Controller 2014-03-13Sell9,137$55.2-11.03view
ANDREOTTI LAMBERTOCEO 2014-03-10Sell100,000$55.52-11.55view
Schmukler Louis SPres., Global Mfg. & Supply 2014-03-10Sell8,799$55.81-12.01view
CORNELIUS JAMES MDirector 2014-03-05Sell100,000$55.82-12.02view
Schmukler Louis SPres., Global Mfg. & Supply 2014-02-28Sell6,088$54.49-9.87view
Caforio GiovanniEVP & Chief Commercial Officer 2014-02-24Sell41,563$54.44-9.79view
Elicker John ESVP Pub Affairs & Inv Relation 2014-02-19Sell9,534$54.22-9.42view
Cuss Francis MEVP & CSO 2014-02-18Sell29,800$54.61-10.07view
LEUNG SANDRAGeneral Counsel & Secretary 2014-02-14Sell10,490$54.28-9.52view
Bancroft Charles AEVP & CFO 2014-02-14Sell52,963$54.35-9.64view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 21 2014 
Abbott Capturing Incremental Market Share Mar 18 2014 
Vanguard Health Care Fund’s Top Five Feb 10 2014 
Bristol-Myers: Don’t Let This One Get Away Jan 15 2014 
AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 
Johnson & Johnson (JNJ) Dividend Stock Analysis Nov 21 2013 
Irving Kahn’s High-Impact Sells in Third Quarter Nov 07 2013 
Abbvie Inc. (ABBV) Dividend Stock Analysis Sep 27 2013 
Kahn Brothers Reduce BMY, SLM, TRV, USG, PFE, LARK in Second Quarter Aug 27 2013 
Renaissance Technologies’ Jim Simons Gouges GOOG, Others in Second Quarter Aug 23 2013 

More From Our Partners
Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog Apr 15 2014 - ZACKS

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide